Smith J A, Fann J I, Miller D C, Moore K A, DeAnda A, Mitchell R S, Stinson E B, Oyer P E, Reitz B A, Shumway N E
Department of Cardiovascular and Thoracic Surgery, Stanford University School of Medicine, CA 94305-5247.
Circulation. 1994 Nov;90(5 Pt 2):II235-42.
Aortic dissection is one of the most lethal potential complications in patients with the Marfan syndrome.
Among 360 patients undergoing operative treatment of aortic dissection between 1963 and 1992, 40 had the Marfan syndrome. There were 24 men and 16 women with a mean age of 35 +/- 9 years (+/- 1 SD; range, 15 to 54 years). These patients included 16 with acute type A, 2 with acute type B, 18 with chronic type A, and 4 with chronic type B aortic dissections. The aortic arch was involved in 29 cases. Preoperative complications included acute aortic valvular insufficiency in 13 patients, rupture into the pericardial space in 3, and loss of peripheral pulses in 9. The site of primary intimal tear was the ascending aorta in 25 patients, the aortic arch in 2, the descending aorta in 7, and not identified in 6. Operations included ascending aortic and aortic valvular replacement (with or without coronary artery reimplantation) in 22 patients, ascending aortic replacement alone in 5, and descending thoracic aortic replacement in 9. Four operative deaths (10 +/- 5% [+/- 70% confidence limits]) occurred in 3 acute patient-years and 1 chronic type A patient-years. Long-term follow-up (216 patient-years; range, 1 month to 22 years; mean, 5.4 years) revealed 15 late deaths, 7 from late aortic sequelae. The overall actuarial survival estimates were 71 +/- 8%, 54 +/- 10%, and 22 +/- 11% at 5, 10, and 15 years, respectively. Twenty late aortic operations were required in 14 patients.
Despite satisfactory early results, the long-term survival of patients with the Marfan syndrome was suboptimal (albeit similar to those without the Marfan syndrome). Future progress will pivot on reducing the incidence of aortic dissection in these patients with medical therapy and/or earlier surgical intervention and enhanced postoperative serial imaging surveillance of the entire aorta.
主动脉夹层是马方综合征患者最致命的潜在并发症之一。
在1963年至1992年间接受主动脉夹层手术治疗的360例患者中,40例患有马方综合征。其中男性24例,女性16例,平均年龄35±9岁(±1标准差;范围15至54岁)。这些患者包括16例急性A型、2例急性B型、18例慢性A型和4例慢性B型主动脉夹层。29例累及主动脉弓。术前并发症包括13例急性主动脉瓣关闭不全、3例破入心包腔和9例外周脉搏消失。原发内膜撕裂部位为升主动脉25例、主动脉弓2例、降主动脉7例、6例未明确。手术包括22例升主动脉和主动脉瓣置换术(伴或不伴冠状动脉再植入)、5例单纯升主动脉置换术和9例胸降主动脉置换术。3例急性患者年和1例慢性A型患者年发生4例手术死亡(10±5%[±70%置信区间])。长期随访(216患者年;范围1个月至22年;平均5.4年)显示15例晚期死亡,7例死于晚期主动脉后遗症。5年、10年和15年的总体精算生存率估计分别为71±8%、54±10%和22±11%。14例患者需要进行20次晚期主动脉手术。
尽管早期结果令人满意,但马方综合征患者的长期生存率仍不理想(尽管与无马方综合征患者相似)。未来的进展将取决于通过药物治疗和/或早期手术干预降低这些患者主动脉夹层的发生率,并加强术后对整个主动脉的连续影像学监测。